Fidelity Select Biotechnology Portfolio Long Term Debt

Fidelity Select Biotechnology Portfolio posts a long-term debt of $0 as of September 2023. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Fidelity Select Biotechnology Portfolio's long-term debt was $0. The latest reading is $0 (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Fidelity Select Biotechnology Portfolio's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for FBIOX's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fidelity Select Biotechnology Portfolio's other metric pages and overview cover the third.